Poractant alfa
- Generic Name
- Poractant alfa
- Brand Names
- Curosurf
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 129069-19-8
- Unique Ingredient Identifier
- KE3U2023NP
- Background
Poractant alfa is a pulmonary surfactant marketed as Curosurf in the United States and Canada. It is used to treat Respiratory Distress Syndrome (RDS) in premature infants with an endogenous pulmonary surfactant deficiency. Poractant alfa is an extract of natural porcine lung surfactant consisting of 99% polar lipids (mainly phospholipids) and 1% hydrophobic...
- Indication
Poractant alfa is indicated for the treatment of Respiratory Distress Syndrome (RDS) in premature infants.
- Associated Conditions
- Respiratory Distress Syndrome
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath